We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Menopause Worsens Symptoms of Rheumatoid Arthritis

By HospiMedica International staff writers
Posted on 14 Feb 2018
A new study suggests that women with rheumatoid arthritis (RA) suffer a greater decline in physical function following menopause.

Researchers at the University of Nebraska Lincoln (UNL; USA), the National Databank for Rheumatic Diseases (NDB; Wichita, KS, USA), and other institutions conducted a study involving 8,189 women who developed RA. More...
Of these, 24.5% were pre-menopausal, 7.5% transitioned through menopause during the study, and 68.1% were post-menopausal. Functional status outcomes were measured using the health assessment questionnaire disability index (HAQ), controlled for confounding variables.

The results showed that women who were pre-menopausal had less functional decline as measured by the HAQ, compared with women who were post-menopausal; the results were robust and strong, even after adjustment for other significant factors. The use of hormonal replacement therapy (HRT), previous pregnancy, and a longer length of reproductive life were associated with less functional decline. After menopause, the trajectory of functional decline worsened and accelerated in women with RA. The study was published on January 28, 2018, in Rheumatology.

“Not only is this decline causing suffering for women, it is costly to both individuals and the healthcare system as a whole,” said lead author Elizabeth Mollard, PhD, APRN-NP. “Research is specifically needed on the mechanism connecting these variables, with the eventual goal of identifying interventions that can maintain or improve function in postmenopausal women with rheumatoid arthritis.”

Women experience RA at a rate three times greater than men, with more severe decline and increased disability. Previous studies have also indicated that women with RA experience shifts in disease status surrounding reproductive and hormonal events. During pregnancy, women have decreased incidence of RA, yet suffer increased incidence of disease development and flare during the post-partum period. Similarly, women who experience early menopause are more likely to develop RA, compared to those who experience normal or late menopause.

Related Links:
University of Nebraska Lincoln
National Databank for Rheumatic Diseases


Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Syringes
Prefilled Saline Flush Syringes
Absorbable Monofilament Mesh
Phasix Mesh
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.